Bellerica, MA, USA), Bid (cat#2002, Cell Signaling, Danvers, MA, USA), AKT (S473) (cat#4058S, Cell Signaling), p53 (cat#S126, Santa Cruz, Santa Cruz, CA,USA), active caspase-3 (cat#9661, Cell Signaling), active caspase-8 (cat#9746, Cell Signaling), caspase-9 (cat#9502, Cell Signaling), DR5 (cat#3696, Cell Signaling), FADD (cat#SC5559, Santa Cruz), RPS6 (S235/236) (cat#2211, Cell Signaling), 4E-BP1 (T37/46) (cat#2855, Cell Signaling), Raptor (cat#2280, Cell Signaling), Rictor (cat#2114, Cell Signaling), mTOR (cat#2983, Cell Signaling), the ER stress sampler (Cat# 9956, Cell signaling), and β-actin (cat#A5441, Sigma).
Targeting FADD in HCT116 cells
Gene targeting vectors were constructed by using the recombinant adeno-associated virus (rAAV) system as previously described (5) . Briefly, two homologous arms (1.312 kb and 1.315 kb, respectively) flanking exon 2 of FADD, along with a neomycin-resistant gene cassette (Neo), were inserted between two Not I sites in the AAV shuttle vector pAAV-MCS (Stratagene, La Jolla, CA). Packaging of rAAV was performed by using the AAV Helper-Free System (Stratagene) according to the manufacturer's instructions.
HCT116 cells containing two copies of WT FADD were infected with the rAAV and selected by G418 (0.5 mg/ml, Mediatech, Manassas, VA) for 3 weeks. Drug-resistant clones were pooled and screened by PCR for targeting events with the following primers: P1 5'-GTGTCACCATGGGTTTCACTC; P2 5'-CCCAAGCTAGTGATGAACTG; NeoF 5'-TCTTGACGAGTTCTTCTGAG; and NeoR 5'-TTGTGCCCAGTCATAGCCG.
Prior to targeting the second allele, the Neo cassette, which is flanked by Lox P sites, was excised from a heterozygous clone by infection with an adenovirus expressing Cre recombinase (Ad-Cre) (6) .
Last updated on 12/29/14 4 Single clones were screened by PCR for Neo excision using P1/P2, and two independent positive clones were infected again with the FADD-targeting construct. After the second round, Neo was again excised by Ad-Cre infection, and gene targeting was verified by PCR and western blotting.
All primer sequences used are listed in Table S2 .
Transfection
The human FADD dominant-negative (FADD-DN) and murine eIF4E expression constructs were kind gifts from Shiyong Sun (Emory University) and Nahum Sonenberg 
